STOCK TITAN

Exscientia to Present at Upcoming Investor Conferences in March

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Exscientia (Nasdaq: EXAI) announced participation of CEO Andrew Hopkins and CFO Ben Taylor in fireside chats at two upcoming investor conferences. The Morgan Stanley EMEA HealthTech Conference is scheduled for March 1, 2022, at 9:00 a.m. ET. The Barclays Global Healthcare Conference will take place on March 16, 2022, at 11:15 a.m. ET. Live webcasts will be available on the company’s website, with archived replays accessible for 30 days post-event. Exscientia is focused on AI-driven drug discovery with over 25 projects in its pipeline.

Positive
  • None.
Negative
  • None.

OXFORD, England--(BUSINESS WIRE)-- Exscientia (Nasdaq: EXAI) today announced that Andrew Hopkins, DPhil., Exscientia’s founder and CEO and Ben Taylor, CFO & Chief Strategy Officer, will participate in fireside chats at the following investor conferences in March:

Morgan Stanley EMEA HealthTech Conference:
Date: Tuesday, March 1, 2022
Time: 9:00 a.m. ET / 2:00 p.m. GMT
Location: Virtual

Barclays Global Healthcare Conference:
Date: Wednesday, March 16, 2022
Time: 11:15 a.m. ET / 4:15 p.m. GMT
Location: Miami, Florida

Live webcasts of the presentations will be available on the Company’s website, under the “Investors & Media” section at www.investors.exscientia.ai. Archived replays of the webcasts will be available for approximately 30 days following the presentation.

About Exscientia

Exscientia is an AI-driven pharmatech company committed to discovering, designing and developing the best possible drugs in the fastest and most effective manner. Exscientia developed the first-ever functional precision oncology platform to successfully guide treatment selection and improve patient outcomes in a prospective interventional clinical study, as well as to progress AI-designed small molecules into the clinical setting. Our pipeline of internal and partnered programmes demonstrates our ability to rapidly translate scientific concepts into precision-designed therapeutic candidates, with more than 25 projects underway. By designing better drugs, faster, we believe the best ideas of science can rapidly become the best medicines for patients.

Exscientia has offices in Oxford, Vienna, Dundee, Boston, Miami, Cambridge (UK) and Osaka. For more information visit us on https://www.exscientia.ai or follow us on Twitter @exscientiaAI.

Investors:

Sara Sherman

investors@exscientia.ai

Media:

Amanda Galgay

media@exscientia.ai

Source: Exscientia

FAQ

What conferences will Exscientia participate in March 2022?

Exscientia will participate in the Morgan Stanley EMEA HealthTech Conference on March 1, 2022, and the Barclays Global Healthcare Conference on March 16, 2022.

What time is the Morgan Stanley EMEA HealthTech Conference?

The Morgan Stanley EMEA HealthTech Conference will take place at 9:00 a.m. ET on March 1, 2022.

Where can I watch the live webcasts for Exscientia's investor presentations?

Live webcasts for Exscientia's presentations can be watched on their website under the 'Investors & Media' section.

How many projects does Exscientia have in its pipeline?

Exscientia has over 25 projects underway in its pipeline.

Who is presenting for Exscientia at the investor conferences?

CEO Andrew Hopkins and CFO Ben Taylor will be presenting for Exscientia at the investor conferences.

Exscientia Plc American Depositary Shares

NASDAQ:EXAI

EXAI Rankings

EXAI Latest News

EXAI Stock Data

633.18M
95.77M
25.9%
20.81%
2.15%
Biotechnology
Healthcare
Link
United States of America
Oxford